Market Closed -
Nasdaq Stockholm
11:29:44 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
181.4
SEK
|
+4.49%
|
|
+12.67%
|
+20.85%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,383
|
2,413
|
5,364
|
1,868
|
2,017
|
2,333
|
-
|
-
|
Enterprise Value (EV)
1 |
1,800
|
2,694
|
5,853
|
2,759
|
2,961
|
3,342
|
3,440
|
3,537
|
P/E ratio
|
61.8
x
|
89.4
x
|
52.7
x
|
155
x
|
114
x
|
88.2
x
|
37.7
x
|
24.7
x
|
Yield
|
0.48%
|
0.43%
|
0.33%
|
0.96%
|
0.89%
|
0.77%
|
0.86%
|
1.06%
|
Capitalization / Revenue
|
1.64
x
|
2.42
x
|
3.89
x
|
1.24
x
|
1.16
x
|
1.15
x
|
0.99
x
|
0.86
x
|
EV / Revenue
|
2.13
x
|
2.7
x
|
4.25
x
|
1.83
x
|
1.7
x
|
1.65
x
|
1.46
x
|
1.3
x
|
EV / EBITDA
|
14.9
x
|
17.1
x
|
21.6
x
|
12.7
x
|
12.1
x
|
11.7
x
|
9.92
x
|
8.71
x
|
EV / FCF
|
-138
x
|
32.3
x
|
51.1
x
|
93.2
x
|
31.3
x
|
36.3
x
|
28.2
x
|
24.4
x
|
FCF Yield
|
-0.72%
|
3.1%
|
1.96%
|
1.07%
|
3.19%
|
2.75%
|
3.55%
|
4.1%
|
Price to Book
|
4.36
x
|
5.39
x
|
10.6
x
|
4.01
x
|
4.17
x
|
4.67
x
|
4.35
x
|
-
|
Nbr of stocks (in thousands)
|
133,335
|
148,335
|
148,335
|
148,938
|
149,652
|
149,652
|
-
|
-
|
Reference price
2 |
10.37
|
16.27
|
36.16
|
12.54
|
13.48
|
15.59
|
15.59
|
15.59
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
844.4
|
997.8
|
1,377
|
1,510
|
1,746
|
2,031
|
2,353
|
2,725
|
EBITDA
1 |
120.7
|
157.5
|
270.4
|
217.4
|
243.8
|
285.8
|
346.8
|
406
|
EBIT
1 |
46.5
|
61.3
|
159.4
|
55.5
|
61.4
|
90.94
|
139.3
|
180.2
|
Operating Margin
|
5.51%
|
6.14%
|
11.57%
|
3.68%
|
3.52%
|
4.48%
|
5.92%
|
6.61%
|
Earnings before Tax (EBT)
1 |
33.3
|
37.3
|
143.8
|
19.8
|
23.6
|
40.52
|
90.57
|
138.3
|
Net income
1 |
22.5
|
25.8
|
101.8
|
12.1
|
17.6
|
26.8
|
62.71
|
96.7
|
Net margin
|
2.66%
|
2.59%
|
7.39%
|
0.8%
|
1.01%
|
1.32%
|
2.66%
|
3.55%
|
EPS
2 |
0.1680
|
0.1820
|
0.6860
|
0.0810
|
0.1180
|
0.1767
|
0.4133
|
0.6300
|
Free Cash Flow
1 |
-13
|
83.5
|
114.5
|
29.6
|
94.5
|
92
|
122
|
145
|
FCF margin
|
-1.54%
|
8.37%
|
8.31%
|
1.96%
|
5.41%
|
4.53%
|
5.18%
|
5.32%
|
FCF Conversion (EBITDA)
|
-
|
53.02%
|
42.34%
|
13.62%
|
38.76%
|
32.19%
|
35.18%
|
35.71%
|
FCF Conversion (Net income)
|
-
|
323.64%
|
112.48%
|
244.63%
|
536.93%
|
343.28%
|
194.56%
|
149.95%
|
Dividend per Share
2 |
0.0500
|
0.0700
|
0.1200
|
0.1200
|
0.1200
|
0.1200
|
0.1333
|
0.1650
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
376.3
|
381.7
|
362.2
|
368.6
|
397.7
|
419.3
|
424.7
|
440.5
|
461.9
|
EBITDA
|
75.1
|
67.5
|
56.2
|
48.8
|
-
|
54.3
|
61.1
|
67.1
|
-
|
EBIT
|
41.6
|
22.5
|
15.2
|
9.1
|
8.7
|
10.7
|
13.2
|
18.5
|
-
|
Operating Margin
|
11.06%
|
5.89%
|
4.2%
|
2.47%
|
2.19%
|
2.55%
|
3.11%
|
4.2%
|
-
|
Earnings before Tax (EBT)
1 |
37.5
|
17.1
|
4
|
-4.2
|
-
|
3
|
9.7
|
0.5
|
10.4
|
Net income
|
27.5
|
12.2
|
1.6
|
-3.6
|
-
|
1.5
|
5.5
|
-
|
-
|
Net margin
|
7.31%
|
3.2%
|
0.44%
|
-0.98%
|
-
|
0.36%
|
1.3%
|
-
|
-
|
EPS
|
-
|
0.0820
|
0.0110
|
-0.0240
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/11/22
|
4/27/22
|
7/22/22
|
11/3/22
|
2/17/23
|
4/27/23
|
7/26/23
|
11/3/23
|
2/9/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
417
|
281
|
489
|
891
|
944
|
1,009
|
1,107
|
1,204
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.452
x
|
1.782
x
|
1.81
x
|
4.098
x
|
3.872
x
|
3.529
x
|
3.191
x
|
2.965
x
|
Free Cash Flow
1 |
-13
|
83.5
|
115
|
29.6
|
94.5
|
92
|
122
|
145
|
ROE (net income / shareholders' equity)
|
7.14%
|
6.74%
|
21.1%
|
2.44%
|
3.6%
|
4.7%
|
11.8%
|
17.7%
|
ROA (Net income/ Total Assets)
|
-
|
2.42%
|
7.28%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,067
|
1,398
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.380
|
3.020
|
3.410
|
3.120
|
3.230
|
3.340
|
3.580
|
-
|
Cash Flow per Share
|
0.6500
|
1.050
|
1.460
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
63.2
|
72.5
|
102
|
141
|
111
|
128
|
188
|
206
|
Capex / Sales
|
7.48%
|
7.27%
|
7.42%
|
9.31%
|
6.33%
|
6.32%
|
8%
|
7.57%
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
Last Close Price
15.59
EUR Average target price
17.01
EUR Spread / Average Target +9.10% Consensus |
1st Jan change
|
Capi.
|
---|
| +20.85% | 2.51B | | +13.70% | 80.61B | | -29.20% | 70.18B | | +9.86% | 29.08B | | -11.43% | 16.97B | | -0.43% | 16.96B | | -0.31% | 15.26B | | +3.42% | 12.41B | | -30.70% | 11.95B | | -6.75% | 11.93B |
Other Healthcare Facilities & Services
|